Cardlytics, Inc.
For the period ended Sep 30, 2025. Filed Nov 5, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2025 · Filed Nov 5, 2025
CDLX$1.63-10.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Balance Sheets (Unaudited)
(Amounts in thousands, except par value amounts)
| September 30, 2025 | December 31, 2024 | |
|---|---|---|
| Assets | ||
| Current assets: | ||
| Cash and cash equivalents | $43,961 | $65,594 |
| Accounts receivable and contract assets, net | 85,496 | 103,252 |
| Other receivables | 5,908 | 3,801 |
| Prepaid expenses and other assets | 5,345 | 5,336 |
| Total current assets | 140,710 | 177,983 |
| Long-term assets: | ||
| Property and equipment, net | 2,206 | 2,596 |
| Right-of-use assets under operating leases, net | 5,328 | 6,341 |
| Intangible assets, net | 7,007 | 11,371 |
| Goodwill | 110,305 | 159,429 |
| Capitalized software development costs, net | 25,595 | 33,341 |
| Other long-term assets, net | 1,656 | 1,650 |
| Total assets | $292,807 | $392,711 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $3,613 | $3,689 |
| Accrued liabilities: | ||
| Accrued compensation | 7,295 | 5,494 |
| Accrued expenses | 7,474 | 7,175 |
| Partner Share liability | 22,153 | 32,479 |
| Consumer Incentive liability | 32,109 | 45,513 |
| Short-term debt | 46,070 | 45,863 |
| Deferred revenue and other liabilities | 3,372 | 2,154 |
| Current operating lease liabilities | 1,617 | 2,025 |
| Current contingent consideration | — | 4,563 |
| Total current liabilities | 123,703 | 148,955 |
| Long-term liabilities: | ||
| Convertible senior notes, net | 168,570 | 167,729 |
| Long-term operating lease liabilities | 5,176 | 6,034 |
| Long-term deferred revenue | 62 | — |
| Total liabilities | $297,511 | $322,718 |
| Stockholders’ equity: | ||
| Common stock, $0.0001 par value—100,000 shares authorized, 53,806 and 51,257 shares issued and outstanding as of September 30, 2025 and December 31, 2024, respectively | $10 | $10 |
| Additional paid-in capital | 1,393,138 | 1,366,958 |
| Accumulated other comprehensive (loss) income | (2,038) | 3,601 |
| Accumulated deficit | (1,395,814) | (1,300,576) |
| Total stockholders’ (deficit) equity | (4,704) | 69,993 |
| Total liabilities and stockholders’ equity | $292,807 | $392,711 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.